Association between ultra-processed food and drink consumption and lipoprotein subclass profiles among middle-to older-aged population: A cross-sectional study
Clinical Nutrition · 2024
DOI: 10.1016/j.clnu.2024.09.005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Nutrition, 2024. Verfasst von Kai Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Surgery Department of the Second Hospital of Jilin University, Changchun, China. Electronic address: kaizhang@vip.126.com. Hauptthemen laut MEDLINE: Fast Foods. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Surgery Department of the Second Hospital of Jilin University, Changchun, China. Electronic address: kaizhang@vip.126.com.
- Cardiovascular Surgery Department of the Second Hospital of Jilin University, Changchun, China.
- Cardiovascular Surgery Department of the Second Hospital of Jilin University, Changchun, China. Electronic address: 108985161@qq.com.
Zitieren
APA
Zhang, K., Wang, Y., Chen, X. X., & Li, B. (2024). Association between ultra-processed food and drink consumption and lipoprotein subclass profiles among middle-to older-aged population: A cross-sectional study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.09.005
Vancouver
Zhang K, Wang Y, Chen XX, Li B. Association between ultra-processed food and drink consumption and lipoprotein subclass profiles among middle-to older-aged population: A cross-sectional study. Clinical Nutrition. 2024. doi:10.1016/j.clnu.2024.09.005
BibTeX
@article{Zhang2024,
author = {Zhang, Kai and Wang, Ye and Chen, Xuan Xuan and Li, Bo},
title = {Association between ultra-processed food and drink consumption and lipoprotein subclass profiles among middle-to older-aged population: A cross-sectional study},
journal = {Clinical Nutrition},
year = {2024},
doi = {10.1016/j.clnu.2024.09.005}
}
EUVIMED